10-121520050-A-T
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PS1PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_000141.5(FGFR2):c.868T>A(p.Trp290Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Pathogenic in Lovd. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. W290C) has been classified as Pathogenic.
Frequency
Consequence
NM_000141.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 17 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGFR2 | ENST00000358487.10 | c.868T>A | p.Trp290Arg | missense_variant | Exon 7 of 18 | 1 | NM_000141.5 | ENSP00000351276.6 | ||
FGFR2 | ENST00000457416.7 | c.868T>A | p.Trp290Arg | missense_variant | Exon 7 of 18 | 1 | ENSP00000410294.2 | |||
FGFR2 | ENST00000369056.5 | c.868T>A | p.Trp290Arg | missense_variant | Exon 6 of 17 | 1 | ENSP00000358052.1 | |||
FGFR2 | ENST00000369058.7 | c.868T>A | p.Trp290Arg | missense_variant | Exon 7 of 17 | 1 | ENSP00000358054.3 | |||
FGFR2 | ENST00000613048.4 | c.601T>A | p.Trp201Arg | missense_variant | Exon 6 of 17 | 5 | ENSP00000484154.1 | |||
FGFR2 | ENST00000369059.5 | c.523T>A | p.Trp175Arg | missense_variant | Exon 5 of 16 | 5 | ENSP00000358055.1 | |||
FGFR2 | ENST00000360144.7 | c.601T>A | p.Trp201Arg | missense_variant | Exon 6 of 17 | 2 | ENSP00000353262.3 | |||
FGFR2 | ENST00000478859.5 | c.184T>A | p.Trp62Arg | missense_variant | Exon 6 of 17 | 1 | ENSP00000474011.1 | |||
FGFR2 | ENST00000369061.8 | c.749-4731T>A | intron_variant | Intron 5 of 14 | 1 | ENSP00000358057.4 | ||||
FGFR2 | ENST00000604236.5 | n.523T>A | non_coding_transcript_exon_variant | Exon 5 of 17 | 1 | ENSP00000474109.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
FGFR2-related craniosynostosis Pathogenic:1
This missense change has been observed in individuals with clinical features of Crouzon syndrome (PMID: 7655462, 16418739, 23431754, 24127277, 24656465; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces tryptophan, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 290 of the FGFR2 protein (p.Trp290Arg). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Trp290 amino acid residue in FGFR2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9475591, 18618990, 24036790, 27683237). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Experimental studies have shown that this missense change affects FGFR2 function (PMID: 20503384). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.